Bayerische Motoren Werke ADR (BMWYY)

Rolls-Royce is set to be a leading provider of electricity for AI data centers.

Dubai and tourism are two things that go hand in hand since there is an indefinite number of people visiting Dubai every year. And by the look of it, this number is only going to increase in the coming years. The reason there is such a demand to visit Dubai is that there is no […]

Steve’s Imports continues to stand out as a reliable auto repair shop in Portland OR by consistently delivering high-quality workmanship paired with attentive, customer-focused service. Known for servicing a wide range of domestic and import vehicles, the shop has built its reputation by focusing on accuracy, transparency, and long-term vehicle reliability. From everyday maintenance to complex diagnostic challenges, every service is approached with the same goal: ensuring customers feel confident in both the work performed and the people performing it.

As of January 16, 2026, the transition of artificial intelligence from digital screens to physical labor has reached a historic turning point. Tesla (NASDAQ: TSLA) has officially moved its Optimus humanoid robots beyond the research-and-development phase, deploying over 1,000 units across its global manufacturing footprint to handle autonomous parts processing. This development marks the dawn [...]

In a move that signals the definitive end of the "viral video" era and the beginning of the industrial humanoid age, Boston Dynamics has officially transitioned its all-electric Atlas robot from the laboratory to the factory floor. As of January 2026, a fleet of the newly unveiled "product-ready" Atlas units has commenced rigorous field tests [...]

The recent vaccine policy changes that the U.S. government announced have astounded experts because the changes reduce recommended vaccines by one third and put the U.S. behinds its peer countries. This change shifts the U.S. from the position of leader on vaccination to a country that lags other developed nations on matters of disease prevention.

The normal practice after someone has undergone a surgical procedure has been to administer anti-inflammatory medications. However, new research conducted at Michigan State University (MSU) suggests that this could be counterproductive and may be the reason why some patients develop chronic pain that lasts for years after their surgery.

AUSTIN, TEXAS — January 14, 2026 — Tesla (NASDAQ: TSLA) has officially transitioned its humanoid robotics program from an ambitious experimental project to a pivotal component of its manufacturing workforce. Recent updates to the Optimus platform—specifically the deployment of the "Version 3" (Gen 3) hardware and FSD-v15 neural architecture—have demonstrated a level of human-like dexterity [...]

Cutaneous T-cell lymphoma, or CTCL, is a rare form of non-Hodgkin lymphoma that primarily affects the skin, often presenting with symptoms that closely resemble common dermatologic conditions such as eczema or psoriasis, leading to frequent misdiagnosis and delayed treatment. These diagnostic delays can allow the disease to progress silently for years, increasing patient suffering and complicating care. A late-stage biopharmaceutical company, Soligenix (NASDAQ: SNGX) is developing therapies aimed at addressing critical gaps in rare disease treatment, including CTCL.

Oragenics (NYSE American: OGEN) announced that it will present at the upcoming Sequire Investor Summit 2026, scheduled for Jan. 20–22, 2026, at the Condado Vanderbilt Hotel in San Juan, Puerto Rico. During the conference, the Company plans to highlight its novel approach to addressing the significant unmet medical need in concussion and mild traumatic brain injury, including progress toward advancing its ONP-002 clinical program into Phase 2a studies, an area where no approved drug therapies currently exist, according to Oragenics Chief Executive Officer Janet Huffman.

As of January 2026, the global automotive industry has reached a pivotal turning point in its architectural evolution. What was once a landscape dominated by proprietary instruction sets has transformed into a competitive "three-pillar" ecosystem, with the open-source RISC-V architecture now commanding a staggering 25% of all new automotive silicon unit shipments. This shift was [...]

Oklahoma City, OK - Expert Auto Care continues to provide trusted automotive repair and maintenance services to drivers across Oklahoma City. The auto repair shop serves both domestic and European vehicles, offering solutions that prioritize long-term reliability, safety, and performance. By combining technical expertise with practical service planning, Expert Auto Care helps customers keep their vehicles in optimal condition year-round.

A new collaboration between Penn State College of Medicine and Targepeutics seeks to advance research into a promising combination therapy that offers hope to families with children diagnosed with DIPG (diffuse intrinsic pontine glioma).

Colibri Car Wrap and Detailing regularly works on vehicles driven in Toronto. The shop handles everything from basic wash and wax services to full paint correction, ceramic coating application, and interior restoration for high-end vehicles that need more than a quick run through an automated car wash. Detailing at this level means multi-step paint decontamination, clay bar treatment to remove bonded contaminants, machine polishing to eliminate swirl marks and light scratches, and protective coatings that actually last instead of washing off after three weeks.

The premium automotive sector faced a stark reality check on January 12, 2026, as shares of Porsche AG (XETRA: P911) tumbled 7% in a single trading session. The sell-off, which wiped billions off the iconic carmaker’s market capitalization, was triggered by a wave of analyst downgrades and a growing

The embattled electric automaker could be on the cusp of a rebound.

Immunotherapy has emerged as a more gentle way to treat cancer over the past few years. However, it is very expensive and results are usually inconsistent among patients, especially those suffering from solid tumors. Researchers in Hong Kong have come up with a biomaterial containing silica that can help to address the current shortcomings of immunotherapy and dramatically improve efficacy rates.

At least 40 million individuals from around the world use ChatGPT each day seeking information on health care-related topics, an analysis conducted by AI tool Knit. The report underscores how people use the technology and the need for oversight so that millions don’t get wrong information on such an important matter as their health.

Estrella Immunopharma (NASDAQ: ESLA, ESLAW) announced the closing of its previously announced registered direct offering with a single healthcare-focused institutional investor, generating aggregate gross proceeds of approximately $8.0 million. The offering included the issuance of 4,063,290 shares of common stock and 1,000,000 pre-funded warrants, together with a concurrent private placement of common warrants to purchase up to 7,594,935 additional shares, with net proceeds expected to be used for general corporate purposes and working capital as the company advances its CD19 and CD22-targeted ARTEMIS T-cell therapy programs, including lead candidate EB103. Aegis Capital Corp. acted as exclusive placement agent for the offerings.

Scinai Immunotherapeutics (NASDAQ: SCNI) announced that Chief Executive Officer Amir Reichman will co-lead a Manufacturers Association of Israel–organized roundtable discussion titled “Biopharma Manufacturing in Israel: Capabilities, Gaps, and Scale” during HealthIL Week 2026. The session, scheduled for Jan. 19, 2026, at Expo Tel Aviv, will focus on Israel’s biopharma development and manufacturing ecosystem, including early-stage development, CMC activities, and clinical manufacturing, as well as readiness for later-stage and commercial manufacturing. The roundtable is expected to bring together representatives from government agencies, biopharma manufacturers, CDMOs, multinational pharmaceutical companies, biotech firms, and investors to examine current capabilities, structural gaps, and collaboration models shaping the sector’s future.

TransCode Therapeutics (NASDAQ: RNAZ) announced the publication of peer-reviewed preclinical research supporting the use of its lead candidate, TTX-MC138, for the treatment of glioblastoma multiforme, one of the most aggressive forms of brain cancer. The study, conducted in collaboration with Michigan State University and published in the Journal of Functional Biomaterials, demonstrated that systemic delivery of TTX-MC138 successfully reached brain tumors in orthotopic glioblastoma models, significantly increased tumor cell apoptosis, and resulted in a statistically significant improvement in survival. The findings further validate TransCode’s TTX delivery platform and support the potential advancement of TTX-MC138 into future clinical evaluation for patients with glioblastoma, building on completed IND-enabling studies and existing Phase 1 clinical experience outside the central nervous system.

Today’s Date: December 26, 2025 Introduction As we close out 2025, NVIDIA Corporation (NASDAQ: NVDA) stands not merely as a semiconductor manufacturer, but as the primary architect of the global "Intelligence Age." Over the past three years, the company has undergone a transformation unparalleled in corporate history, evolving from a high-end graphics card provider into [...]

The World Health Organization (WHO), the agency of the United Nations responsible for overseeing matters related to global health, revealed that 2025 was marked by notable progress in ensuring populations around the world were supported to have good health. However, climate shocks, conflicts and funding cuts strained many health systems around the world and put a damper on the prospects for sustained improvements to health in the years to come.

As of December 24, 2025, Tesla, Inc. (NASDAQ: TSLA) stands at a pivotal juncture in its corporate history. While long perceived primarily as an electric vehicle (EV) manufacturer, the company is undergoing a fundamental transformation into a diversified powerhouse of energy storage and physical artificial intelligence. This shift has propelled the stock to record-breaking highs, [...]

The era of the "hard-coded" robot has officially come to an end. In a series of landmark developments culminating in early 2026, the robotics industry has undergone a fundamental shift from rigid, rule-based programming to "End-to-End" (E2E) neural networks. This transition has transformed humanoid machines from clumsy laboratory experiments into capable workers that can learn [...]